WRAL Tech Wire

RTP broadband firm Overture, minus two top execs, launches new look

The global provider of Ethernet related broadband services shortens its name, creates a new logo and revamps its websites. The changes come in the post-Hatteras Network merger, and among the recent moves is the departure of the former Hatteras CEO.

Overture's new logo

CH-based Cempra goes public, raises $50M; shares close up 6 cents

Cempra Pharmaceuticals sells 8.4 million shares at $6 each. The pricing had been expected to be higher.

Cempra

North Carolina venture deals sluggish in '11 but VCs remain upbeat

Deal making totaled only $325 million across 47 deals, the lowest total since 2005 when one excludes the recession year of 2009. Life science deals dominate the fourth quarter.

Transenterix landed $15M in 4Q for its Spider surgical system

NC-based Cempra Pharmaceuticals aims to raise $89.7M in public offering

The Chapel Hill-based company wants to sell 6 million shares at a price between $11 and $13 a share. Its underwriters have the right to sell another 900,000 shares.

Cempra

TransEnterix CEO has 'great expectations' for new $15M in funding

Investors in the Research Triangle Park-based medical device company include Aisling Capital, Intersouth Partners, Quaker Partners, SV Life Science Advisers, Synergy Life Science Partners and Parish Capital Advisors.

Transenterix landed $15M in 4Q for its Spider surgical system

Intersouth leads $4.5M investment in electronic health records provider

SimplifyMD, a Georgia-based firm, also names a former McKesson executive as its president. As part of the deal, Intersouth's John Glushnik joins the startup's board.

Cempra Pharmaceuticals files plans for $86M IPO

Cempra does not yet have any Food and Drug Administration-approved products. Its compounds are targeting an antibiotics market that according to Datamonitor totaled $19.6 billion in the United States, Japan and the five major European markets in 2009.

Charlotte IT firm raises $6M, adds Red Hat exec to board

Adaptivity raises funds from Intersouth Partners, Noro-Moseley Partners and Intel Capital. The software firm also names a new chief technology officer.

Cancer diagnostics startup raises $250,000

GeneCentric Dianostics, which is based in Durham, is led by Hatteras Venture Partners' Myla Lai-Goldman.

Frey back in executive saddle as EvoApp CEO

Kip Frey, who left Zenph Sound Innovations last month, is the new CEO at EvoApp.

Raleigh 'cloud' startup raises $7M, plans 5-10 new hires

6fusion, which is backed by Intersouth partners, lands a new investor in raising its second investment round.

6fusion's "Cube" concept for managing the "cloud"

Semiconductor firm Nitronex raises $2M in debt offering

The Durham-based company hopes to raise another $3.5 million, according to an SEC filing.

Startup Cempra Pharmaceuticals raises $5M in new capital

The Chapel Hill-based company has two clinical stage antibacterial compounds; one of which is being developed to fight nasty skin infections.

Well-known VC Kip Frey steps down as Zenph Sound CEO

Longtime Triangle venture capitalist and entrepreneur Kip Frey resigned Friday as chief executive of Durham-based music technology company Zenph Sound Innovations.

John Walker prepares for a concert.

Venture-backed Cempra explores funding options

The Chapel Hill firm is developing potential antibacterial drugs to combat superbugs. Will it seek more venture funding or a partnership with a bigger pharmaceutical firm?